• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. EB EXC 5GRN/5WHT 30IN 2-0 D/A V-5 10PLGT; SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. EB EXC 5GRN/5WHT 30IN 2-0 D/A V-5 10PLGT; SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE Back to Search Results
Catalog Number SXX54
Medical Device Problem Codes Material Frayed (1262); Material Separation (1562)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 10/11/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
 
Event or Problem Description
It was reported that a patient underwent an unknown procedure on (b)(6) 2019 and suture was used.The suture was fraying and the needle was popping off the suture.It was not reported how the procedure was completed.There was a short delay in the procedure.There were no patient consequences reported.
 
Additional Manufacturer Narrative
(b)(4).A manufacturing record evaluation was performed for the finished device lot peu034, and no non-conformances were identified.Additional investigation summary: an opened msda folder with six strands double armed, a dispensed suture and five suture pieces of product code sxx54, lot # peu034 were received for evaluation.During the visual inspection of a dispensed suture and five suture pieces, the ends were noted cut and appears to be caused due to use of a surgical instrument and no fraying was noted on the surface suture.In handling this or any other suture material, care should be taken to avoid damage from handling.Avoid crushing or crimping damage due to application of surgical instruments such as forceps or needle holders.During the visual inspection of the six strands, the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along of the strand and no defects, damaged or fraying were observed.A functional test was performed and the pull force were above the minimum requirements.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.Per the condition of the sample received no fraying sutures were noted and, the assignable cause of the performance pull off suture needle is an improper handling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EB EXC 5GRN/5WHT 30IN 2-0 D/A V-5 10PLGT
Common Device Name
SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key9288078
Report Number2210968-2019-89639
Device Sequence Number16732349
Product Code GAT
UDI-Device Identifier10705031050716
UDI-Public10705031050716
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K946173
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2024
Device Catalogue NumberSXX54
Device Lot NumberPEU034
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/13/2019
Initial Date Received by Manufacturer 10/11/2019
Supplement Date Received by Manufacturer11/13/2019
Initial Report FDA Received Date11/06/2019
Supplement Report FDA Received Date12/03/2019
Patient Sequence Number1
-
-